Innoviva, Inc.'s Net Worth
-$45.4 Million
Who is Innoviva, Inc.?
Innoviva, Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Armata Pharmaceuticals, Inc., Entasis Therapeutics Holdings Inc., and Theravance Biopharma, Inc..
SEC CIK
Innoviva, Inc.'s CIK is 0001080014
Past Insider Trading and Trends
2020 was Innoviva, Inc.'s most active year for acquiring shares with 6 total transactions. Innoviva, Inc.'s most active month to acquire stocks was the month of February. 2014 was Innoviva, Inc.'s most active year for disposing of shares, totalling 1 transactions. Innoviva, Inc.'s most active month to dispose stocks was the month of April. 2020 saw Innoviva, Inc. paying a total of $132,686,823.10 for 50,136,096 shares, this is the most they've acquired in one year. In 2014 Innoviva, Inc. cashed out on 33,100,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Armata Pharmaceuticals, Inc. (ARMP) Snapshot price: $2.4
InvestorInnoviva, Inc. owns 8,710,800 units of Common Stock which is worth $20,905,920.00. In the year 2022 Innoviva, Inc. acquired a total of 7,717,661 shares in Armata Pharmaceuticals, Inc. at a cost of $22,149,687.07.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
| +49.04% | 5.39M |
$5.00 | $26,926,040.00 | 16.37M |
Mar 31
| |||
Form 4
| +49.07% | 3.61M |
$5.00 | $18,073,960.00 | 10.98M |
Feb 9
| |||
Form 4
| +19.70% | 1.21M |
$3.30 | $4,000,002.60 | 7.37M |
Oct 29
| |||
Form 4
| +229.45% | 4.29M |
$3.25 | $13,929,288.75 | 6.15M |
Mar 17
| |||
Form 4
|
∞
| 1.87M |
$3.25 | $6,070,714.00 | 1.87M |
Jan 26
| |||
Form 4
| +777.10% | 7.72M |
$2.87 | $22,149,687.07 | 8.71M |
Mar 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Entasis Therapeutics Holdings Inc. No price found
InvestorInnoviva, Inc. owns 18,672,897 units of Common Stock. In the year 2022 Innoviva, Inc. filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +192.70% | 19.27M |
$2.20 | $42,395,047.20 | 29.27M |
Jul 8 - Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| +168.02% | 6.27M |
$2.00 | $12,537,950.00 | 10M |
Jun 11
| |||
Form 4
|
∞
| 3.73M |
$2.00 | $7,462,050.00 | 3.73M |
May 3
| |||
Form 4
| +33.38% | 4.67M |
$2.68 | $12,499,999.48 | 18.67M |
Sep 1
| |||
Form 4
| +958.59% | 12.68M |
$2.50 | $31,693,725.00 | 14M |
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.01
InvestorInnoviva, Inc. used to own units in Common Stock but no longer holds any shares there. In the year 2014 Innoviva, Inc. filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -33.10M |
—
|
—
|
0
|
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||